# Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients

> **NCT01697969** · PHASE4 · COMPLETED · sponsor: **Alcon Research** · enrollment: 17 (actual)

## Conditions studied

- Allergic Conjunctivitis

## Interventions

- **DRUG:** Olopatadine hydrochloride ophthalmic solution, 0.2%

## Key facts

- **NCT ID:** NCT01697969
- **Lead sponsor:** Alcon Research
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-07
- **Final completion:** 2013-07
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2014-08-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01697969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01697969, "Confocal Analysis of Corneal Structures of Symptomatic Allergic Conjunctivitis Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01697969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*